| Literature DB >> 26165442 |
Bradley C Clark1, Justin Georgekutty2, Charles I Berul2.
Abstract
K2 is a synthetic cannabinoid that has potential cardiovascular side effects, including myocardial ischemia, myocardial infarction, and arrhythmias. Cardiac testing of pediatric patients is often not performed owing to a lack of symptomatology. We report a series of pediatric patients with concern for myocardial ischemia temporally associated with K2 exposure.Entities:
Mesh：
Substances：
Year: 2015 PMID： 26165442 DOI： 10.1016/j.jpeds.2015.06.001
Source DB: PubMed Journal: J Pediatr ISSN： 0022-3476 Impact factor: 4.406